Market Screener
Filter stocks by sector, industry, market cap, valuation, growth, and technicals — in a dense table layout.
| No. | Ticker | Company | Sector | Industry | Country | Market Cap (B) ▲ | P/E | Price | Chg. % | Volume |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MDXH | MDxHealth SA | Healthcare | Diagnostics & Research | US | 0.0 $ | — | 0.63 $ | -6.20% | 959,086 |
| 2 | PRPO | Precipio Inc | Healthcare | Diagnostics & Research | US | 0.0 $ | — | 26.40 $ | -0.20% | 68,935 |
| 3 | QUCY | Quantum Cyber N.V. | Healthcare | Diagnostics & Research | US | 0.1 $ | — | 1.40 $ | +1.50% | 1,036,531 |
| 4 | IMDX | Insight Molecular Diagnostics Inc. | Healthcare | Diagnostics & Research | US | 0.1 $ | — | 4.00 $ | +1.30% | 153,512 |
| 5 | BNR | Burning Rock Biotech Ltd | Healthcare | Diagnostics & Research | US | 0.2 $ | — | 14.20 $ | +5.30% | 13,487 |
| 6 | XGN | Exagen Inc | Healthcare | Diagnostics & Research | US | 0.2 $ | — | 8.40 $ | +6.90% | 181,214 |
| 7 | BDSX | Biodesix Inc | Healthcare | Diagnostics & Research | US | 0.3 $ | — | 29.10 $ | +1.10% | 94,893 |
| 8 | MYGN | Myriad Genetics Inc | Healthcare | Diagnostics & Research | US | 0.4 $ | — | 3.90 $ | -6.00% | 2,031,607 |
| 9 | FLGT | Fulgent Genetics Inc | Healthcare | Diagnostics & Research | US | 0.6 $ | — | 21.70 $ | -0.70% | 244,745 |
| 10 | CSTL | Castle Biosciences Inc | Healthcare | Diagnostics & Research | US | 1.1 $ | — | 35.30 $ | -3.90% | 305,329 |
| 11 | OPK | Opko Health Inc | Healthcare | Diagnostics & Research | US | 1.3 $ | — | 1.70 $ | +3.10% | 1,891,047 |
| 12 | PSNL | Personalis Inc | Healthcare | Diagnostics & Research | US | 1.8 $ | — | 16.40 $ | +1.00% | 7,996,300 |
| 13 | FRNM | Freenome, Inc. | Healthcare | Diagnostics & Research | US | 1.8 $ | — | 17.10 $ | +5.00% | 1,060,373 |
| 14 | NEO | NeoGenomics Inc | Healthcare | Diagnostics & Research | US | 2.6 $ | — | 19.90 $ | +0.10% | 4,309,385 |
| 15 | CDNA | CareDx Inc | Healthcare | Diagnostics & Research | US | 2.8 $ | — | 53.80 $ | -0.80% | 1,315,840 |
| 16 | WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | US | 2.9 $ | — | 101.10 $ | -3.70% | 1,191,816 |
| 17 | VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | US | 3.2 $ | 37.23 | 39.80 $ | -1.90% | 1,243,792 |
| 18 | GRAL | GRAIL, LLC | Healthcare | Diagnostics & Research | US | 3.5 $ | — | 80.80 $ | +1.00% | 598,518 |
| 19 | ADPT | Adaptive Biotechnologies Corp | Healthcare | Diagnostics & Research | US | 4.6 $ | — | 28.60 $ | +0.20% | 3,959,044 |
| 20 | BLLN | BillionToOne, Inc. | Healthcare | Diagnostics & Research | US | 5.0 $ | 151.35 | 105.90 $ | -4.30% | 572,693 |
| 21 | SHC | Sotera Health Co | Healthcare | Diagnostics & Research | US | 5.3 $ | 46.36 | 18.70 $ | -1.20% | 2,287,561 |
| 22 | RDNT | RadNet Inc | Healthcare | Diagnostics & Research | US | 5.9 $ | — | 76.00 $ | -2.30% | 838,737 |
| 23 | QGEN | Qiagen NV | Healthcare | Diagnostics & Research | US | 9.2 $ | 23.59 | 43.30 $ | -2.40% | 3,487,868 |
| 24 | TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | US | 10.4 $ | — | 167.00 $ | +7.30% | 2,780,879 |
| 25 | ICLR | ICON PLC | Healthcare | Diagnostics & Research | US | 12.7 $ | 252.43 | 164.10 $ | -3.30% | 647,040 |
| 26 | CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | US | 13.0 $ | — | 278.10 $ | -1.30% | 1,535,978 |
| 27 | RVTY | Revvity Inc. | Healthcare | Diagnostics & Research | US | 15.9 $ | 66.98 | 143.50 $ | -2.20% | 1,896,540 |
| 28 | MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | US | 17.0 $ | 38.96 | 612.30 $ | -0.50% | 400,884 |
| 29 | GH | Guardant Health Inc | Healthcare | Diagnostics & Research | US | 23.8 $ | — | 179.40 $ | -2.00% | 2,543,747 |
| 30 | LH | Labcorp Holdings Inc. | Healthcare | Diagnostics & Research | US | 26.4 $ | 28.60 | 320.70 $ | -0.60% | 365,268 |
| 31 | DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | US | 27.4 $ | 27.88 | 246.50 $ | -0.40% | 632,250 |
| 32 | MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | US | 28.1 $ | 32.98 | 1,392.30 $ | -1.30% | 337,346 |
| 33 | ILMN | Illumina Inc | Healthcare | Diagnostics & Research | US | 36.2 $ | 42.66 | 239.60 $ | -2.30% | 2,806,601 |
| 34 | IDXX | IDEXX Laboratories Inc | Healthcare | Diagnostics & Research | US | 40.7 $ | 38.04 | 511.70 $ | +1.00% | 617,152 |
| 35 | WAT | Waters Corporation | Healthcare | Diagnostics & Research | US | 41.4 $ | 52.38 | 421.60 $ | -1.90% | 923,640 |
| 36 | A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | US | 44.3 $ | 31.02 | 156.50 $ | +0.10% | 2,026,784 |
| 37 | IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | US | 44.7 $ | 33.51 | 266.40 $ | -1.10% | 1,284,044 |
| 38 | NTRA | Natera Inc | Healthcare | Diagnostics & Research | US | 53.2 $ | — | 369.40 $ | +0.80% | 2,423,183 |
| 39 | DHR | Danaher Corporation | Healthcare | Diagnostics & Research | US | 149.6 $ | 41.71 | 211.80 $ | -0.30% | 6,090,900 |
| 40 | TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | US | 239.4 $ | 36.46 | 651.50 $ | -1.00% | 2,275,842 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).